AzTrials
AzTrials

HealthyNE+NCT07460973

Nen ŨnkUmbi/EdaHiYedo Plus (We Are Here Now Plus): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth

A study testing NE+ in people with Healthy and Condom Use, run by Montana State University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

We Are Here Now - Plus (NE+) is a holistic, culturally centered, and multilevel intervention for American Indian youth to improve sexual health, mental health, and substance use outcomes. Read more about this study

Who is it for?
Ages 12 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Healthy, Condom Use, Mental Health
What is being tested?
NE+
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
843 participants
Where
1 siteUnited States
Study dates
23 Mar 2026to 1 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • 12 to 18 years old
  • Registered member of a federally recognized tribe or an associate tribal member
  • Resident of the Fort Peck Reservation with a caregiver who agrees for their child to participate in the intervention

Who cannot join

  • Not meeting any of the aforementioned inclusion criteria
  • Having a medically identified physical or cognitive impairment that would impede their understanding of and participation in the educational content, activities, and teachings of the intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Elizabeth L Rink, PhD, MSW contact

406-600-0297

elizabeth.rink@montana.edu

Molly Secor, PhD contact

molly.secor@montana.edu

United States1 site, 1 recruiting
  • Fort Peck Community College

    Bozeman, Montana, 59715

    Olivia Johnson, MA, 406-786-7427, ojohnson@fpcc.edu

    Ashley Solheim-Azure, AA, (406)480-9389, aazure@fpcc.edu

    Recruiting

Other trials in United States

About this study

Official title: Nen ŨnkUmbi/EdaHiYedo Plus (NE+): a Multi-level Intervention to Reduce Health Disparities Among American Indian Youth

We Are Here Now - Plus (NE+) is a holistic, culturally centered, and multilevel intervention for American Indian youth to improve sexual health, mental health, and substance use outcomes. The goal of this intervention is to learn if NE+ can decrease substance use during sex, decrease sexual activity, increase condom use, increase positive mental health, increase caregiver(parent)-youth communication, increase communication between school personnel and youth, and increase utilization of clinical services. Researchers will compare one intervention arm to one control arm to see if the aforementioned indicators improve among the intervention arm for youth participants.

Youth participants (ages 12-18) will participate in a 9-month educational program consisting of 18 modules that discuss healthy relationships, puberty \& physiology (separate girls \& boys), parenting, pregnancy and sexually transmitted infections (STIs) and Human Immunodeficiency Virus (HIV) prevention, sexual avoidant behaviors with a focus on abstinence, substance use prevention with a focus on abstinence and refusal skills, \& positive mental health, resources; skills (high school)- self-efficacy, refusal skills, decision making, communication, abstinence; skills (middle school) - health knowledge, self-efficacy, boundaries, communication, abstinence. Youth will also participate in six teachings offered by local cultural leaders that coincide with educational modules, including: kinship networks \& family; cultural values; 7 sacred roles of tribal members; ceremonies; cultural teachings and responsibilities of women \& men in tribe \& ceremonies; Indigenous worldview; skills - knowledge of traditional ways, language \& cultural people to go to for help; community members roles \& responsibilities in tribe \& ceremonies.

Read more

Caregiver (parent) participants will participate in three in-person visits/meetings to discuss the following: visit 1 - age specific physical, cognitive, emotional, spiritual development; visit 2: prevention of substance use, promoting positive mental health, promotion of healthy relationships; skills -communication with youth; visit 3 - pregnancy and STIs/HIV prevention and abstinence from sex, parental monitoring, tribal resources.

School personnel participants will participate in three workshops during teacher in-service training days, including the following information: Workshop 1 - cultural teachings on kinship \& family networks, cultural values, cultural age \& community roles; Workshop 2 - sexual risk avoidant behaviors, substance use prevention, positive mental health promotion, pregnancy STIs/HIV prevention, tribal resources; Workshop 3 - culturally respectful communication skills by age \& youth (boy/girl) and age \& caregiver (male/female); skills - knowledge of cultural ways, substance use prevention, positive mental health promotion, sexual risk avoidant behaviors, culturally respectful communication.

Being tested
NE+, Control
Keywords
Sexual and reproductive health, Mental health, Substance use
Medical subject headings
Psychological Well-Being, Substance-Related Disorders, Coitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NE+Behavioural

    School-based learning intervention consisting of 18 learning modules taught over 9 months.

  • ControlBehavioural

    Participants will not receive any educational material in this arm and will only provide survey responses to act as control observations.

Study groups in NCT07460973
Study groupRoleWhat they receive
NE+ interventionExperimentalNot described
Receives: Behavioral: NE+
ControlPlacebo comparatorNot described
Receives: Behavioral: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in mean condom use frequency relative to sexual intercourse frequency in the past month

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  2. Change from baseline in mean number of participants reporting if they have ever had sexual intercourse

    Measuring the mean number of youth who report having ever had sex to examine if youth in the intervention arm have less initiation of sexual intercourse compared to youth in control arm.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  3. Change from baseline in mean age when participants first engage in sexual intercourse

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  4. Change from baseline in mean number of lifetime sex partners

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  5. Change from baseline in mean number of recent (past-month) sex partners

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  6. Change from baseline in mean number of times participants recently (in the past month) engaged in sexual intercourse

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  7. Change from baseline in mean number of times birth control was used during sexual intercourse

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  8. Change from baseline in mean depressive symptoms score

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  9. Change in baseline in mean number of youth who have ever smoked a cigarette

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  10. Change from baseline in mean anxiety score

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  11. Change from baseline in mean age of youth initiating tobacco use

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  12. Change from baseline in mean number of days (of past 30 days) youth reported smoking cigarettes

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  13. Change from baseline in mean number of youth who reported ever using an electronic vapor product

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  14. Change from baseline in mean number of times injection drugs were used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  15. Change from baseline in mean number of times injection drugs were used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  16. Change from baseline in mean number of times hallucinogenic drugs were used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  17. Change from baseline in mean number of times ecstasy was used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  18. Change from baseline in mean number of times methamphetamines were used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  19. Change from baseline in mean number of times heroin was used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  20. Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  21. Change from baseline in mean number of times cocaine was used in past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  22. Change from baseline in mean number of times hallucinogenic drugs (e.g., acid) were used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  23. Change from baseline in mean number of times ecstasy was used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  24. Change from baseline in mean number of times methamphetamines were used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  25. Change from baseline in mean number of times heroin was used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  26. Change from baseline in mean number of times glue, aerosol spray, or other inhalants were used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  27. Change from baseline in mean number of times any form of cocaine has been used in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  28. Change from baseline in mean number of times prescription pain medicine without doctor's prescription was used in the past 30 days

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  29. Change from baseline in mean number of times prescription pain medicine was used without a doctor's prescription in lifetime

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  30. Change from baseline in mean number of times in the past 30 days youth reported using marijuana

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  31. Change from baseline in mean age at which youth reported first using marijuana for the first time

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  32. Change from baseline in mean number of times youth reported using marijuana in their life

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  33. Change from baseline in mean number of drinks (in the past 30 days) that youth reported having in a row

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  34. Change from baseline in mean number of days (in past 30 days) youth reported having 4 or more drinks of alcohol in a row (for males) or 5 or more drinks of alcohol in a row (for females)

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  35. Change from baseline in mean number of days (in past 30 days) youth reported having at least one drink of alcohol

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  36. Change from baseline in the mean age at which youth reported having alcohol for the first time

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  37. Change from baseline in mean number of days (in past 30 days) youth reported using an electronic vapor product

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

Secondary outcomes (10)
  1. Change from baseline in mean condom use self-efficacy score derived from Talashek's Condom Use Self Efficacy Scale

    Talashek's condom use self-efficacy scale consists of 6 questions regarding condom use self-efficacy (e.g., "I could get condoms") with likert-type responses ranging from 1-5 (1 Yes, I could; 2 Maybe I could; 3 Don't Know; 4 Probably I could not; 5 No, I could not). Scores from each item will be summed to create a sum score between 5 and 30.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  2. Change from baseline in mean condom use intention score derived from one question with a likert-type response set from the Youth Health Risk Behavioral Inventory

    One single question asks youth how likely it is that they intend to use a condom the next time they have sex, assessed by a likert-type response set of answers ranging from 1-5, where 1 is the least likely and 5 is the most likely.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  3. Change from baseline in mean beliefs about birth control score from the pathways of choice survey

    18 questions from the pathways of choice survey, each with a likert-type response set (1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree) will be summed to create a composite score between 18 and 90.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  4. Change from baseline in mean score of knowledge of healthy relationships from the Native STAND (students together against negative decisions) survey

    10 questions from the Native STAND survey ask participants if a certain characteristic is representative of a healthy relationship. Participants respond "no" or "yes", where answers of "no" are coded to 0 and "yes" coded to 1. All answers will be summed to create a composite score from 0 to 10.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  5. Change from baseline in mean sexual refusal score derived from a sexual refusal scale from the sexual refusal skills regarding sex

    Participants are asked 7 questions pertaining to their confidence in being able to refuse sex in different scenarios. The responses range from 1-5 (1, I Definitely Can Say No; 2, I Can Say No; 3, I Don't Know; 4, I Can't Say No; 5, I Definitely Can't Say No). All responses will be summed to create a composite score ranging from 7 to 35.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  6. Change from baseline in mean score on knowledge of sexually transmitted infections and other sexual health items

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  7. Change from baseline in mean caregiver-youth communication score derived from the Parent-Adolescent Communication Scale

    Participants are asked 5 questions about how often they speak with their parents about topics regarding sexual health (e.g., "In the past 6 months, how often have you and y our parent(s) talked about how to use condoms?"), where responses range from 0=never, 1=rarely, 2=sometimes, and 3=often. Responses are summed to create a composite score ranging from 0 to 15.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  8. Change from baseline in mean caregiver-adolescent openness score derived from the Parent-adolescent communication scale

    Participants are asked 10 questions regarding their openness with their parents (e.g., "I can discuss my beliefs with my mother/father without feeling restrained or embarrassed"), where responses are: 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree. Responses will be summed to create a composite score ranging from 10 to 50.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  9. Change from baseline in mean cultural connectedness score derive from the cultural connectedness scale (short form)

    Participants are asked 10 questions regarding how connected they feel to their culture in three different domains (identity, spirituality, and traditions). Response sets include 1=yes and 0=no, as well as likert-type responses (1=strongly disagree, 2=somewhat disagree, 3=neither agree nor disagree, 4=somewhat agree, 5=strongly agree). Responses will be summed to create a composite score for cultural connectedness ranging from 0 to 30.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

  10. Change from baseline in mean communication score between youth and school personnel derived from an adapted Ambulatory Care Experiences (ACE) survey.

    Participants are asked 8 questions about their communication and relationship with school personnel, with response sets from 1, Strongly disagree; 2, Somewhat disagree; 3, Neither disagree nor agree; 4, Somewhat agree; 5, Strongly agree. Responses will be summed to create a composite score from 8 to 40.

    Measured: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2026
  2. Study start23 Mar 2026
  3. Primary completion1 May 2029 (estimated)
  4. Study completion1 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
843 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07460973
Sponsor's protocol ID
R01MD012761-07
Other IDs
R01MD012761-07
Acronym
NE+
Status last verified
May 2026
First submitted
27 Feb 2026
Last updated
12 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing NE+ in people with Healthy and Condom Use, run by Montana State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elizabeth L Rink, PhD, MSW (406-600-0297, elizabeth.rink@montana.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in mean condom use frequency relative to sexual intercourse frequency in the past month (time frame: From baseline to 9 months post-baseline, 14 months post-baseline, and 26 months post-baseline). The study lists 37 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in